Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/β-catenin signaling pathway in alveolar bone of ovariectomized rats

Abstract

Recent studies have shown that Er-Zhi-Wan (EZW), a traditional Chinese medicine consisting of Herba Ecliptae (HE) and Fructus Ligustri Lucidi (FLL), had a definite antiosteoporotic effect on osteoporotic femur, but its effect on osteoporosis of alveolar bone remains unknown. In the present study, we investigated the effects of Er-Zhi-Wan (EZW) on the microarchitecture and the regulation of Wnt/β-catenin signaling pathway in the alveolar bone of ovariectomized rats. Thirty Sprague-Dawley rats were randomly divided into three groups: sham operation group (sham, n=10), ovariectomy (OVX) group (n=10), and OVX with EZW treatment group (EZW group, n=10). From one week after ovariectomy, EZW (100 mg/mL) or vehicle (distilled water) was fed (1 mL/100 g) once per day for 12 weeks until the sacrifice of the rats. The body weights were measured weekly. After sacrifice, the sera and mandible were collected and routinely prepared for the measurement of alveolar trabecular microarchitecture, serum levels of E2, bone-specific alkaline phosphatase (BALP) and tartrate-resistant acid phosphatase 5b (TRAP5b), as well as mandibular mRNA expression of Wnt/β-catenin signaling pathway molecules wnt3a, low-density lipoprotein receptor-related protein 5 (LRP5), β-catenin and dickkopf homolog 1 (DKK1). The results showed that EZW treatment significantly prevented the body weight gain, degradation of alveolar trabecular microarchitecture and alveolar bone loss in the OVX rats. Furthermore, we observed that EZW could increase the serum levels of E2 and BALP, and decrease levels of serum TRAP5b in EZW group compared with vehicle group. In addition, RT-PCR results revealed that EZW upregulated the expression levels of wnt3a, LRP5 and β-catenin, and reduced the expression of DKK1 in OVX rats. Taken together, our results suggested that EZW may have potential anti-osteoporotic effects on osteoporotic alveolar bone by stimulating Wnt/LRP5/β-catenin signaling pathway.

Keywords

osteoporosis / Er-Zhi-Wan / alveolar bone / Wnt signaling pathway

References

[1] BirkenfeldL, YeminiM, KaseNG, et al.. Menopause- related oral alveolar bone resorption: a review of relatively unexplored consequences of estrogen deficiency. Menopause, 1999, 6(2): 129-133

[2] HildeboltCF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol, 1997, 26(1): 3-15

[3] PayneJB, ReinhardtRA, NummikoskiPV, et al.. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int, 1999, 10(1): 34-40

[4] TanakaM, EjiriS, ToyookaE, et al.. Effects of ovariectomy on trabecular structures of rat alveolar bone. J Periodontal Res, 2002, 37(2): 161-165

[5] TanakaM, ToyookaE, KohnoS, et al.. Long-term changes in trabecular structure of aged rat alveolar bone after ovariectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003, 95(4): 495-502

[6] StevensonJC. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas, 2005, 51(2): 113-126

[7] PrelevicGM, KocjanT, MarkouA. Hormone replacement therapy in postmenopausal women. Minerva Endocrinol, 2005, 30(1): 27-36

[8] ChengM, WangQ, FanY, et al.. A traditional Chinese herbal preparation, Er-Zhi-Wan, prevent ovariectomy-induced osteoporosis in rats. J Ethnopharmacol, 2011, 138(2): 279-285

[9] ZhangH, XingWW, LiYS, et al.. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas, 2008, 61(4): 334-339

[10] XuH, SuZR, HuangW, et al.. Er Zhi Wan, an ancient herbal decoction for woman menopausal syndrome, activates the estrogenic response in cultured MCF-7 cells: an evaluation of compatibility in defining the optimized preparation method. J Ethnopharmacol, 2012, 143(1): 109-115

[11] HoeppnerLH, SecretoFJ, WestendorfJJ. Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets, 2009, 13(4): 485-496

[12] KulkarniNH, OnyiaJE, ZengQ, et al.. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res, 2006, 21(6): 910-920

[13] KaluDN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner, 1991, 15(3): 175-191

[14] GillesJA, CarnesDL, DallasMR, et al.. Oral bone loss is increased in ovariectomized rats. J Endod, 1997, 23(7): 419-422

[15] SugimotoM, FutakiN, HaradaM, et al.. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate. Bone, 2013, 52(1): 181-188

[16] CavaniF, FerrettiM, CarnevaleG, et al.. Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats. J Bone Miner Metab, 2012, 30(6): 619-629

[17] PengS, LiuXS, WangT, et al.. In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells. J Orthop Res, 2010, 28(9): 1208-1214

[18] ErenE, YilmazN. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major. Int J Clin Pract, 2005, 59(1): 46-51

[19] DervisE. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100(3): 349-356

[20] SeemanE, DelmasPD. Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med, 2006, 354(21): 2250-2261

[21] McDonnellP, McHughPE, O’MahoneyD. Vertebral osteoporosis and trabecular bone quality. Ann Biomed Eng, 2007, 35(2): 170-189

[22] LiY, LiX, SongG, et al.. Effects of strontium ranelate on osseointegration of titanium implant in osteoporotic rats. Clin Oral Implants Res, 2012, 23(9): 1038-1044

[23] HujaSS, FernandezSA, HillKJ, et al.. Indentation modulus of the alveolar process in dogs. J Dent Res, 2007, 86(3): 237-241

[24] AmesMS, HongS, LeeHR, et al.. Estrogen deficiency increases variability of tissue mineral density of alveolar bone surrounding teeth. Arch Oral Biol, 2010, 55(8): 599-605

[25] YangJ, PhamSM, CrabbeDL. Effects of oestrogen deficiency on rat mandibular and tibial microarchitecture. Dentomaxillofac Radiol, 2003, 32(4): 247-251

[26] MariePJ, KassemM. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol, 2011, 165(1): 1-10

[27] KrishnanV, BryantHU, MacdougaldOA. Regulation of bone mass by Wnt signaling. J Clin Invest, 2006, 116(5): 1202-1209

[28] BodinePV, KommBS. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord, 2006, 7(1–2): 33-39